Does Medica Cover Ozempic?
The verdict
Conditional on most plans
Medica covers Ozempic for type 2 diabetes with prior authorization — it does not cover Ozempic for off-label weight-loss use under any Medica plan. As a Minnesota nonprofit regional plan, Medica follows standard clinical PA criteria for T2D medications. Minnesota Medicaid (Medical Assistance) separately covers GLP-1s for obesity with PA — but that state-level coverage applies to on-label obesity medications and does not translate to Medica covering Ozempic for weight loss. Formulary tier and cost-share are not publicly confirmed at the drug level.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Medica using your member ID.
Key facts
Ozempic is FDA-approved for type 2 diabetes glycemic control and cardiovascular risk reduction in T2D patients — not for weight loss.
FDA drug labeling (semaglutide injection)
Minnesota Medical Assistance covers GLP-1s for obesity (Wegovy, Zepbound) as on-label anti-obesity medications — this does not extend to Ozempic for off-label weight loss.
KFF, Medicaid Coverage of and Spending on GLP-1s
The IRA Maximum Fair Price for semaglutide under Medicare is $274 per 30-day supply, effective January 1, 2027.
CMS, IRA Drug Price Negotiation Program, 2024
Medicare vs. commercial coverage
Whether Medica covers Ozempic depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Advantage (Medica Prime): Ozempic is covered for type 2 diabetes with prior authorization. PA requires a documented T2D diagnosis and evidence of metformin step-therapy or a documented contraindication. The 2026 Part D out-of-pocket cap of $2,100 limits annual beneficiary spending. Medicare Advantage enrollees cannot use the NovoCare savings card — federal anti-kickback rules exclude Medicare and Medicaid beneficiaries. The IRA Maximum Fair Price for semaglutide is $274 per 30-day supply, effective January 1, 2027. Ozempic is not covered for weight loss under Medicare Advantage.
Commercial / Employer
Group & marketplace plans
Commercial/Employer: Medica covers Ozempic for type 2 diabetes with prior authorization and metformin step-therapy. Formulary tier is not publicly confirmed at the drug level — verify on Medica's drug-lookup tool or call member services. Commercially insured T2D patients may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150 per 28-day supply) — verify at NovoCare.com. Not covered for off-label weight loss. ACA/Individual: covered for T2D with PA; not covered for weight loss. Medicaid (Medica Healthcare managed care in MN, IA): covered for type 2 diabetes with prior authorization and nominal Medicaid cost-share. Not covered for off-label weight loss. Note: Minnesota Medical Assistance (state Medicaid) covers Wegovy and Zepbound for obesity with PA — this is a state PDL decision for on-label anti-obesity medications, not a Medica commercial policy, and it does not extend to Ozempic for weight-loss use under any Medica plan. Medicaid enrollees cannot use the NovoCare savings card.
The 3 boxes you must tick to get approved
Commercial plans that will consider Ozempic require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Ozempic actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$1,028/month (Novo Nordisk published pricing, ~$1,027.51 for the 0.25/0.5 mg pen). NovoCare self-pay: ~$199/month intro price (first two fills through December 31, 2026), then ~$349/month (0.25/0.5/1 mg) or ~$499/month (2 mg).
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial: plan-specific cost-share — not publicly confirmed; verify on Medica drug-lookup tool. Medicare Advantage: cost-share depends on plan tier; $2,100 Part D OOP cap applies in 2026; IRA Maximum Fair Price of $274/30-day for semaglutide takes effect January 1, 2027. Medicaid: nominal Medicaid cost-share per MN/IA state PDL.
Typical monthly copay once prior authorization is approved.
Bridge program
NovoCare Ozempic Savings Card: commercially insured T2D patients may pay as little as $25 per fill (max $150 per 28-day supply). Not available to Medicare, Medicaid, VA, DoD, or TRICARE beneficiaries. Verify eligibility at NovoCare.com.
Reduced copay through the assistance program, where eligible.
All figures are estimates — verify exact cost-share with Medica member services or on the Medica drug-lookup tool. Tier placement and cost-share vary by specific plan and line of business.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Ozempic on Medica's drug/formulary tool
Log in to your Medica member account at medica.com and use the drug or formulary lookup to confirm Ozempic's tier and any prior-authorization or step-therapy requirements on your specific plan. Commercial, Medicare Advantage, and Medicaid plans may have different tier placements.
- 2
Have your prescriber submit the prior-authorization request
Ask your provider to submit a PA request to Medica documenting: a T2D diagnosis (ICD-10 E11.x), evidence of metformin use or a documented contraindication. The clinical indication must be type 2 diabetes — not weight management. Medica's nonprofit orientation means the PA process is typically straightforward for established T2D medications when the clinical record is complete.
- 3
Clarify MN Medicaid GLP-1 coverage if you are a Medicaid enrollee
If you are on Medica's Medicaid managed-care plan in Minnesota or Iowa, verify your state's current PDL for Ozempic T2D coverage. Note: MN Medical Assistance covers Wegovy and Zepbound for obesity — those are on-label weight-management medications; Ozempic is covered through the T2D pathway only. Call Medica member services for current Medicaid formulary details.
Options if Medica won't cover Ozempic
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Rybelsus (oral semaglutide)
Oral semaglutide tablet for type 2 diabetes. Also covered for T2D with PA on most formularies. Subject to the IRA Maximum Fair Price of $274/30-day effective January 1, 2027 for Medicare patients. Verify tier on Medica drug-lookup.
Jardiance (empagliflozin)
SGLT-2 inhibitor commonly used as step-therapy before GLP-1 approval. Often at a lower cost-share tier than Ozempic on commercial and Medicaid formularies.
Metformin (generic)
First-line oral diabetes medication universally covered at low or no cost. Required as step therapy before Ozempic PA in most Medica plans.
Compounded semaglutide (weight-loss seekers only)
For Minnesota and upper Midwest patients seeking semaglutide for weight management who are denied by Medica's commercial plans, compounded semaglutide from $49/mo is available at getcurex.com/cl/glp without insurance. See the Curex offer section below for full disclaimers.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. Medica does not cover Ozempic for weight loss under any plan. Ozempic holds FDA approval for type 2 diabetes and cardiovascular risk reduction in T2D patients — not for weight management. This applies to Medica commercial, ACA, Medicare Advantage, and Medicaid plans equally. The fact that Minnesota Medicaid separately covers Wegovy and Zepbound for obesity does not change this: that state-level AOM coverage is for on-label obesity medications, not Ozempic off-label. Medica cannot cover Ozempic for weight loss regardless of what MN Medicaid does for on-label AOMs.
Yes, Medica covers Ozempic for type 2 diabetes with prior authorization across its commercial, ACA, Medicare Advantage, and Medicaid plans in Minnesota and its other states. Your prescriber must document a T2D diagnosis and metformin step-therapy or a contraindication. Medica's formulary details are not publicly confirmed at the drug level — verify on the Medica drug-lookup tool or call member services. As a regional nonprofit, the PA process for established T2D medications is typically accessible and clinically straightforward.
No. Minnesota Medical Assistance (state Medicaid) covers Wegovy and Zepbound for obesity as on-label anti-obesity medications — this is a separate state PDL decision that does not affect Medica's commercial plan formulary. Medica's commercial plans cover Ozempic for type 2 diabetes with PA; they do not cover Ozempic for weight loss, regardless of what the state Medicaid program covers for on-label obesity medications. If you are on Medica Medicaid and have an obesity diagnosis without T2D, contact Medica Medicaid member services about coverage for on-label AOMs through the state PDL.
Commercially insured T2D patients on a Medica commercial plan may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150 per 28-day supply) — verify eligibility at NovoCare.com. Medicare Advantage and Medicaid enrollees cannot use the savings card; federal anti-kickback rules exclude government program beneficiaries. If you are on a Medica commercial plan in Minnesota or another state with a confirmed T2D diagnosis, this card can materially reduce out-of-pocket cost.
Medica and BCBS of Minnesota both cover Ozempic for type 2 diabetes with prior authorization; both exclude weight-loss use. The key difference is documentation depth: BCBS of Minnesota, as a larger nationally affiliated insurer, may have more publicly accessible formulary detail. Medica, as a regional nonprofit, has less per-drug formulary information available through third-party sources — verify directly via Medica's member portal or member services call. Coverage outcomes for T2D are equivalent.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreInsurance won't cover Ozempic for weight loss — here's a path that doesn't need it
Medica does not cover Ozempic for weight loss — and Minnesota's permissive Medicaid AOM coverage applies only to on-label obesity medications, not to Ozempic off-label. For Minnesota and upper Midwest patients seeking semaglutide for weight management without insurance coverage, Curex offers compounded semaglutide starting at $49/mo with no prior authorization needed. Compounded tirzepatide is also available from $149/mo. Compounded semaglutide is not the same medication as Ozempic or Wegovy. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Ozempic and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Medica before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Ozempic and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.